Cancer biotech raising $20m after delaying Nasdaq float

SYDNEY: Sydney-based biotech EnGeneIC is tapping investors to raise $20 million in bridging ... read more

IFM and UniSuper buy radiology business

SYDNEY: One of Australia’s biggest asset managers, IFM Investors, has teamed up with ... read more

GenesisCare gets waiver but buys time for recap

SYDNEY: Cancer care group GenesisCare has bought a bit more time in its ... read more

Medibank class action could go all the way

SYDNEY: A class-action lawsuit over Medibank’s huge data breach could find itself in ... read more